Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Prostate Cancer

Free Subscription 09.07.2018 5 Anticancer Res 1 BJU Int 3 Cancer 1 Cancer Res 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 Invest Radiol 1 Magn Reson Imaging 1 PLoS One 1 Urol Int

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Anticancer Res

1. TAMARI K, Oh RJ, Masai N, Shiomi H, et al
   Long-term Outcomes of Radiotherapy Regimen of 72 Gy in 30 Fractions for Prostate Cancer.
   Anticancer Res. 2018;38:4207-4212.
   PubMed     Text format     Abstract available
   
   
2. MIYAKE H, Matsushita Y, Watanabe H, Tamura K, et al
   Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.
   Anticancer Res. 2018;38:4179-4185.
   PubMed     Text format     Abstract available
   
   
3. MURAKAMI T, Obata H, Akitake N, Shiota M, et al
   Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer.
   Anticancer Res. 2018;38:4115-4121.
   PubMed     Text format     Abstract available
   
   
4. LIAO CH, Wu HC, Hu PS, Hsu SW, et al
   The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients.
   Anticancer Res. 2018;38:3907-3911.
   PubMed     Text format     Abstract available
   
   
5. LEIGHTON X, Bera A, Eidelman O, Eklund M, et al
   High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer.
   Anticancer Res. 2018;38:3831-3842.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

6. DAHRAN N, Szewczyk-Bieda M, Vinnicombe S, Fleming S, et al
   Periprostatic Fat Adipokines Expression Correlated with Prostate Cancer Aggressiveness in Men Undergoing Radical Prostatectomy for Clinically Localised Disease.
   BJU Int. 2018 Jul 3. doi: 10.1111/bju.14469.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

7. ALONGI F, Corradini S, Arcangeli S
   Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?
   Cancer. 2018 Jul 5. doi: 10.1002/cncr.31626.
   PubMed     Text format    
   
   
8. DALL'ERA MA, Lo MJ, Chen JY, Cress R, et al
   Reply to Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture?
   Cancer. 2018 Jul 5. doi: 10.1002/cncr.31625.
   PubMed     Text format    
   
   
9. KING MT, Nguyen PL, Boldbaatar N, Tempany CM, et al
   Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer.
   Cancer. 2018 Jul 5. doi: 10.1002/cncr.31568.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

10. 
    Correction: Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer.
    Cancer Res. 2018;78:3740.
    PubMed     Text format    
    
    

    
    Int J Cancer

11. PEREZ-CORNAGO A, Appleby PN, Boeing H, Gil L, et al
    Circulating isoflavone and lignan concentrations and prostate cancer risk: A meta-analysis of individual participant data from seven prospective studies including 2828 cases and 5593 controls.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31640.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

12. CICCHETTI A, Avuzzi B, Palorini F, Ballarini F, et al
    Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer: New Insights From External Independent Validation.
    Int J Radiat Oncol Biol Phys. 2018 Jun 30. pii: S0360-3016(18)30806.
    PubMed     Text format     Abstract available
    
    

    
    Invest Radiol

13. BARRETT T, Riemer F, McLean MA, Kaggie J, et al
    Quantification of Total and Intracellular Sodium Concentration in Primary Prostate Cancer and Adjacent Normal Prostate Tissue With Magnetic Resonance Imaging.
    Invest Radiol. 2018;53:450-456.
    PubMed     Text format     Abstract available
    
    

    
    Magn Reson Imaging

14. MAZAHERI Y, Hotker AM, Shukla-Dave A, Akin O, et al
    Model selection for high b-value diffusion-weighted MRI of the prostate.
    Magn Reson Imaging. 2017 Oct 11. pii: S0730-725X(17)30219.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

15. BOURKE L, Turner R, Greasley R, Sutton E, et al
    A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS.
    PLoS One. 2018;13:e0197606.
    PubMed     Text format     Abstract available
    
    

    
    Urol Int

16. PORCARO AB, Tafuri A, Sebben M, Corsi P, et al
    Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
    Urol Int. 2018;101:1-9.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: